Bottom line
What does FTDZX hold?
FTDZX held 126 positions as of Jul 31, 2026. Its largest holding is Jazz Pharmaceuticals plc at 5.66% of the fund, and the top 10 positions add up to 36.3%. By asset type it is 97% stocks, 1% preferred stock, 5% cash & short-term funds.
Updated Sep 25, 2026
FTDZX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Jazz Pharmaceuticals plc | Stocks | 5.66% | $65.3M |
| 2 | Amgen, Inc. | Stocks | 4.39% | $50.7M |
| 3 | Gilead Sciences, Inc. | Stocks | 3.86% | $44.5M |
| 4 | Regeneron Pharmaceuticals, Inc. | Stocks | 3.77% | $43.5M |
| 5 | Argenx SE | Stocks | 3.62% | $41.8M |
| 6 | Vertex Pharmaceuticals, Inc. | Stocks | 3.54% | $40.8M |
| 7 | Franklin Institutional U.S. Government Money Market Fund | Cash & short-term funds | 3.18% | $36.7M |
| 8 | Revolution Medicines, Inc. | Stocks | 3.01% | $34.8M |
| 9 | Guardant Health, Inc. | Stocks | 2.76% | $31.8M |
| 10 | Ascendis Pharma A/S | Stocks | 2.56% | $29.6M |
| 11 | Dianthus Therapeutics, Inc. | Stocks | 2.32% | $26.8M |
| 12 | Insmed, Inc. | Stocks | 1.99% | $23.0M |
| 13 | Mirum Pharmaceuticals, Inc. | Stocks | 1.98% | $22.8M |
| 14 | Praxis Precision Medicines, Inc. | Stocks | 1.91% | $22.1M |
| 15 | Spyre Therapeutics, Inc. | Stocks | 1.87% | $21.6M |
| 16 | Oruka Therapeutics, Inc. | Stocks | 1.86% | $21.5M |
| 17 | Neurocrine Biosciences, Inc. | Stocks | 1.82% | $21.0M |
| 18 | Bridgebio Pharma, Inc. | Stocks | 1.67% | $19.3M |
| 19 | PTC Therapeutics, Inc. | Stocks | 1.65% | $19.0M |
| 20 | AstraZeneca plc | Stocks | 1.51% | $17.4M |
| 21 | Franklin Institutional U.S. Government Money Market Fund | Cash & short-term funds | 1.45% | $16.7M |
| 22 | Amylyx Pharmaceuticals, Inc. | Stocks | 1.32% | $15.3M |
| 23 | Eli Lilly & Co. | Stocks | 1.31% | $15.1M |
| 24 | Cytokinetics, Inc. | Stocks | 1.24% | $14.3M |
| 25 | Tango Therapeutics, Inc. | Stocks | 1.23% | $14.2M |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 25, 2026